Resources from the same session
4391 - TAGS: a phase 3, randomised, double-blind study of trifluridine/tipiracil (TAS-102) versus placebo in patients with refractory metastatic gastric cancer
Presenter: Hendrik-Tobias Arkenau
Session: Proffered paper session - Gastrointestinal tumours, non colorectal
Resources:
Abstract
Slides
Webcast
1405 - Randomized phase III study of Gemcitabine, Cisplatin plus S-1 (GCS) versus Gemcitabine, Cisplatin (GC) for Advanced Biliary Tract Cancer (KHBO1401-MITSUBA)
Presenter: Daisuke Sakai
Session: Proffered paper session - Gastrointestinal tumours, non colorectal
Resources:
Abstract
Slides
Webcast
Proffered paper session - Gastrointestinal tumours, non colorectal - Invited Discussant 615O
Presenter: Juan Valle
Session: Proffered paper session - Gastrointestinal tumours, non colorectal
Resources:
Slides
Webcast
2728 - Updated safety and clinical activity results from a Phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC)
Presenter: Michael Pishvaian
Session: Proffered paper session - Gastrointestinal tumours, non colorectal
Resources:
Abstract
Slides
Webcast
792 - A Randomized Multicentered Phase 2 Study to Evaluate SHR-1210 (PD-1 Antibody) in Subjects with Advanced Hepatocellular Carcinoma (HCC) who Failed or Intolerable to Prior Systemic Treatment
Presenter: Shu Qin
Session: Proffered paper session - Gastrointestinal tumours, non colorectal
Resources:
Abstract
Slides
Webcast
Proffered paper session - Gastrointestinal tumours, non colorectal - Invited Discussant LBA26 and LBA27
Presenter: Michel Ducreux
Session: Proffered paper session - Gastrointestinal tumours, non colorectal
Resources:
Slides
Webcast